ALQ – Macquarie rates the stock as Outperform

Macquarie believes the strong momentum in the first quarter should continue, based on the key indicators. In particular, Latin America has shown a strong improvement.

At its AGM the company also noted tight markets, expecting robust demand will underpin pricing in FY22.

The EUR145m acquisition of a 49% stake in Nuvisan is expected to close shortly and Macquarie suspects, going forward, bolt-on acquisition potential in life science will remain in focus. Outperform rating maintained. Target is $13.80.

Sector: Commercial & Professional Services.

 

Target price is $13.80.Current Price is $12.72. Difference: $1.08 – (brackets indicate current price is over target). If ALQ meets the Macquarie target it will return approximately 8% (excluding dividends, fees and charges – negative figures indicate an expected loss).

 

 

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →